John Gary Csernansky - Publications

Northwestern University, Evanston, IL 
schizophrenia, Alzheimer's Disease

253 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Cobia D, Rich C, Smith MJ, Engel Gonzalez P, Cronenwett W, Csernansky JG, Wang L. Thalamic Shape Abnormalities Differentially Relate to Cognitive Performance in Early-Onset and Adult-Onset Schizophrenia. Frontiers in Psychiatry. 13: 803234. PMID 35479490 DOI: 10.3389/fpsyt.2022.803234  0.705
2022 Alden EC, Smith MJ, Reilly JL, Wang L, Csernansky JG, Cobia DJ. Shape features of working memory-related deep-brain regions differentiate high and low community functioning in schizophrenia. Schizophrenia Research. Cognition. 29: 100250. PMID 35368990 DOI: 10.1016/j.scog.2022.100250  0.682
2021 Gutman BA, van Erp TGM, Alpert K, Ching CRK, Isaev D, Ragothaman A, Jahanshad N, Saremi A, Zavaliangos-Petropulu A, Glahn DC, Shen L, Cong S, Alnaes D, Andreassen OA, Doan NT, ... ... Csernansky JG, et al. A meta-analysis of deep brain structural shape and asymmetry abnormalities in 2,833 individuals with schizophrenia compared with 3,929 healthy volunteers via the ENIGMA Consortium. Human Brain Mapping. PMID 34498337 DOI: 10.1002/hbm.25625  0.694
2021 Cobia D, Rich C, Smith MJ, Mamah D, Csernansky JG, Wang L. Basal ganglia shape features differentiate schizoaffective disorder from schizophrenia. Psychiatry Research. Neuroimaging. 317: 111352. PMID 34399283 DOI: 10.1016/j.pscychresns.2021.111352  0.688
2021 Karpouzian-Rogers T, Cobia D, Petersen J, Wang L, Mittal VA, Csernansky JG, Smith MJ. Cognitive Empathy and Longitudinal Changes in Temporo-Parietal Junction Thickness in Schizophrenia. Frontiers in Psychiatry. 12: 667656. PMID 34054621 DOI: 10.3389/fpsyt.2021.667656  0.676
2020 Lewis-de Los Angeles CP, Williams PL, Jenkins LM, Huo Y, Malee K, Alpert KI, Uban KA, Herting MM, Csernansky JG, Nichols SL, Van Dyke RB, Sowell ER, Wang L. Brain morphometric differences in youth with and without perinatally-acquired HIV: A cross-sectional study. Neuroimage. Clinical. 26: 102246. PMID 32251906 DOI: 10.1016/J.Nicl.2020.102246  0.308
2020 Kraus MS, Gold JM, Barch DM, Walker TM, Chun CA, Buchanan RW, Csernansky JG, Goff DC, Green MF, Jarskog LF, Javitt DC, Kimhy D, Lieberman JA, McEvoy JP, Mesholam-Gately RI, et al. The characteristics of cognitive neuroscience tests in a schizophrenia cognition clinical trial: Psychometric properties and correlations with standard measures. Schizophrenia Research. Cognition. 19: 100161. PMID 31832342 DOI: 10.1016/J.Scog.2019.100161  0.324
2019 Andorn A, Graham J, Csernansky J, Newcomer JW, Shinde S, Muma G, Heidbreder C, Fava M. Monthly Extended-Release Risperidone (RBP-7000) in the Treatment of Schizophrenia: Results From the Phase 3 Program. Journal of Clinical Psychopharmacology. PMID 31343440 DOI: 10.1097/Jcp.0000000000001076  0.35
2019 Cobia D, Gale S, Lindsey H, Hedges D, Wyman C, Smith M, Csernansky J, Wang L, Yolken R. S89. CYTOMEGALOVIRUS SEROPOSITIVITY IS ASSOCIATED WITH REGIONAL CORTICAL THINNING IN SCHIZOPHRENIA Schizophrenia Bulletin. 45: S341-S341. DOI: 10.1093/Schbul/Sbz020.634  0.694
2019 Andorn A, Graham J, Fava M, Csernansky J, Newcomer JW, Walling D, Shinde S, Muma G, Heidbreder C. F27. EFFICACY OF MONTHLY EXTENDED-RELEASE RISPERIDONE INJECTIONS (RBP-7000) FOR THE TREATMENT OF SCHIZOPHRENIA: AN ANALYSIS OF INDIVIDUAL PANSS ITEMS Schizophrenia Bulletin. 45: S264-S265. DOI: 10.1093/Schbul/Sbz018.439  0.344
2018 Kukreja L, Shahidehpour R, Kim G, Keegan J, Sadleir KR, Russell T, Csernansky J, Mesulam M, Vassar RJ, Wang L, Dong H, Geula C. Differential Neurotoxicity Related to Tetracycline Transactivator and TDP-43 Expression in Conditional TDP-43 Mouse Model of Frontotemporal Lobar Degeneration. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 29807909 DOI: 10.1523/Jneurosci.1836-17.2018  0.366
2018 Gao R, Piguel NH, Melendez-Zaidi AE, Martin-de-Saavedra MD, Yoon S, Forrest MP, Myczek K, Zhang G, Russell TA, Csernansky JG, Surmeier DJ, Penzes P. CNTNAP2 stabilizes interneuron dendritic arbors through CASK. Molecular Psychiatry. PMID 29610457 DOI: 10.1038/S41380-018-0027-3  0.302
2018 Dong H, Keegan JM, Hong E, Gallardo C, Montalvo-Ortiz J, Wang B, Rice KC, Csernansky J. Corticotrophin releasing factor receptor 1 antagonists prevent chronic stress-induced behavioral changes and synapse loss in aged rats. Psychoneuroendocrinology. 90: 92-101. PMID 29477954 DOI: 10.1016/J.Psyneuen.2018.02.013  0.683
2017 Rodríguez G, Neugebauer NM, Yao KL, Meltzer HY, Csernansky JG, Dong H. Δ9-tetrahydrocannabinol (Δ9-THC) administration after neonatal exposure to phencyclidine potentiates schizophrenia-related behavioral phenotypes in mice. Pharmacology, Biochemistry, and Behavior. PMID 28648819 DOI: 10.1016/J.Pbb.2017.06.010  0.395
2017 Karpouzian TM, Schroeder MP, Abram SV, Wanar H, Alden EC, Eack SM, Csernansky JG, Smith MJ. Neural correlates of preserved facial affect perception in high functioning schizophrenia. Psychiatry Research. 266: 83-85. PMID 28624640 DOI: 10.1016/J.Pscychresns.2017.06.002  0.387
2017 Montalvo-Ortiz JL, Fisher DW, Rodríguez G, Fang D, Csernansky JG, Dong H. Histone deacetylase inhibitors reverse age-related increases in side effects of haloperidol in mice. Psychopharmacology. PMID 28421257 DOI: 10.1007/S00213-017-4629-2  0.681
2017 Fox JM, Abram SV, Reilly JL, Eack S, Goldman MB, Csernansky JG, Wang L, Smith MJ. Default Mode Functional Connectivity Is Associated With Social Functioning in Schizophrenia. Journal of Abnormal Psychology. PMID 28358526 DOI: 10.1037/Abn0000253  0.385
2017 Paula Lewis-De Los Angeles C, Williams PL, Huo Y, Wang SD, Uban KA, Herting MM, Malee K, Yogev R, Csernansky JG, Nichols S, Van Dyke RB, Sowell ER, Wang L. Lower Total and Regional Grey Matter Brain Volumes in Youth with Perinatally-Acquired HIV Infection: Associations with HIV Disease Severity, Substance Use, and Cognition. Brain, Behavior, and Immunity. PMID 28089557 DOI: 10.1016/J.Bbi.2017.01.004  0.322
2017 Cobia D, Perry C, Gale S, Hedges D, Smith M, Wang L, Csernansky J. SA79. Toxoplasma Gondii Affects Posterior Association Cortex and Related Functions in Healthy, but Not Schizophrenia, Individuals Schizophrenia Bulletin. 43: S141-S141. DOI: 10.1093/Schbul/Sbx023.077  0.7
2016 Abram SV, Wisner KM, Fox JM, Barch DM, Wang L, Csernansky JG, MacDonald AW, Smith MJ. Fronto-temporal connectivity predicts cognitive empathy deficits and experiential negative symptoms in schizophrenia. Human Brain Mapping. PMID 27774734 DOI: 10.1002/Hbm.23439  0.436
2016 Massey SH, Stern D, Alden EC, Petersen JE, Cobia DJ, Wang L, Csernansky JG, Smith MJ. Cortical thickness of neural substrates supporting cognitive empathy in individuals with schizophrenia. Schizophrenia Research. PMID 27665257 DOI: 10.1016/J.Schres.2016.09.025  0.676
2016 Cobia DJ, Smith MJ, Salinas I, Ng C, Gado M, Csernansky JG, Wang L. Progressive deterioration of thalamic nuclei relates to cortical network decline in schizophrenia. Schizophrenia Research. PMID 27613507 DOI: 10.1016/J.Schres.2016.08.003  0.716
2016 Blizinsky KD, Diaz-Castro B, Forrest MP, Schürmann B, Bach AP, Martin-de-Saavedra MD, Wang L, Csernansky JG, Duan J, Penzes P. Reversal of dendritic phenotypes in 16p11.2 microduplication mouse model neurons by pharmacological targeting of a network hub. Proceedings of the National Academy of Sciences of the United States of America. PMID 27402753 DOI: 10.1073/Pnas.1607014113  0.37
2016 Mamah D, Alpert KI, Barch DM, Csernansky JG, Wang L. Subcortical neuromorphometry in schizophrenia spectrum and bipolar disorders. Neuroimage. Clinical. 11: 276-86. PMID 26977397 DOI: 10.1016/J.Nicl.2016.02.011  0.39
2015 Herting MM, Uban KA, Williams PL, Gautam P, Huo Y, Malee K, Yogev R, Csernansky J, Wang L, Nichols S, Van Dyke R, Sowell ER. Default Mode Connectivity in Youth With Perinatally Acquired HIV. Medicine. 94: e1417. PMID 26376381 DOI: 10.1097/Md.0000000000001417  0.309
2015 Coccaro EF, Lee R, McCloskey M, Csernansky JG, Wang L. Morphometric analysis of amygdla and hippocampus shape in impulsively aggressive and healthy control subjects. Journal of Psychiatric Research. 69: 80-6. PMID 26343598 DOI: 10.1016/J.Jpsychires.2015.07.009  0.375
2015 Uban KA, Herting MM, Williams PL, Ajmera T, Gautam P, Huo Y, Malee KM, Yogev R, Csernansky JG, Wang L, Nichols SL, Sowell ER. White matter microstructure among youth with perinatally acquired HIV is associated with disease severity. Aids (London, England). 29: 1035-44. PMID 26125138 DOI: 10.1097/Qad.0000000000000648  0.3
2015 Smith MJ, Cobia DJ, Reilly JL, Gilman JM, Roberts AG, Alpert KI, Wang L, Breiter HC, Csernansky JG. Cannabis-related episodic memory deficits and hippocampal morphological differences in healthy individuals and schizophrenia subjects. Hippocampus. PMID 25760303 DOI: 10.1002/Hipo.22427  0.722
2015 Jarskog LF, Lowy MT, Grove RA, Keefe RS, Horrigan JP, Ball MP, Breier A, Buchanan RW, Carter CS, Csernansky JG, Goff DC, Green MF, Kantrowitz JT, Keshavan MS, Laurelle M, et al. A Phase II study of a histamine H₃ receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy. Schizophrenia Research. 164: 136-42. PMID 25728831 DOI: 10.1016/J.Schres.2015.01.041  0.387
2015 Varghese SP, Montalvo-Ortiz JL, Csernansky JG, Eiger RI, Herrold AA, Koola MM, Dong H. Early Life Stress as a Risk Factor for Substance use Disorders: Clinical and Neurobiological Substrates. Indian Journal of Psychological Medicine. 37: 36-41. PMID 25722510 DOI: 10.4103/0253-7176.150816  0.673
2015 Harms MP, Akhter KD, Csernansky JG, Mori S, Barch DM. Fractional anisotropy in individuals with schizophrenia and their nonpsychotic siblings. Psychiatry Research. 231: 87-91. PMID 25453989 DOI: 10.1016/J.Pscychresns.2014.10.009  0.373
2015 Smith MJ, Schroeder MP, Abram SV, Goldman MB, Parrish TB, Wang X, Derntl B, Habel U, Decety J, Reilly JL, Csernansky JG, Breiter HC. Alterations in brain activation during cognitive empathy are related to social functioning in schizophrenia. Schizophrenia Bulletin. 41: 211-22. PMID 24583906 DOI: 10.1093/Schbul/Sbu023  0.356
2014 Barch DM, Cohen R, Csernansky J. Altered cognitive development in the siblings of individuals with schizophrenia. Clinical Psychological Science : a Journal of the Association For Psychological Science. 2: 138-151. PMID 25485180 DOI: 10.1177/2167702613496244  0.392
2014 Russell TA, Blizinsky KD, Cobia DJ, Cahill ME, Xie Z, Sweet RA, Duan J, Gejman PV, Wang L, Csernansky JG, Penzes P. A sequence variant in human KALRN impairs protein function and coincides with reduced cortical thickness. Nature Communications. 5: 4858. PMID 25224588 DOI: 10.1038/Ncomms5858  0.695
2014 Womer FY, Wang L, Alpert KI, Smith MJ, Csernansky JG, Barch DM, Mamah D. Basal ganglia and thalamic morphology in schizophrenia and bipolar disorder. Psychiatry Research. 223: 75-83. PMID 24957866 DOI: 10.1016/J.Pscychresns.2014.05.017  0.415
2014 Dong H, Wang S, Zeng Z, Li F, Montalvo-Ortiz J, Tucker C, Akhtar S, Shi J, Meltzer HY, Rice KC, Csernansky JG. Effects of corticotrophin-releasing factor receptor 1 antagonists on amyloid-β and behavior in Tg2576 mice. Psychopharmacology. 231: 4711-22. PMID 24862368 DOI: 10.1007/S00213-014-3629-8  0.656
2014 Montalvo-Ortiz JL, Keegan J, Gallardo C, Gerst N, Tetsuka K, Tucker C, Matsumoto M, Fang D, Csernansky JG, Dong H. HDAC inhibitors restore the capacity of aged mice to respond to haloperidol through modulation of histone acetylation. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1469-78. PMID 24366052 DOI: 10.1038/Npp.2013.346  0.679
2014 Smith MJ, Cobia DJ, Wang L, Alpert KI, Cronenwett WJ, Goldman MB, Mamah D, Barch DM, Breiter HC, Csernansky JG. Cannabis-related working memory deficits and associated subcortical morphological differences in healthy individuals and schizophrenia subjects. Schizophrenia Bulletin. 40: 287-99. PMID 24342821 DOI: 10.1093/Schbul/Sbt176  0.718
2013 Cronenwett WJ, Csernansky JG. Diving deep into white matter to improve our understanding of the pathophysiology of schizophrenia. Biological Psychiatry. 74: 396-7. PMID 23968985 DOI: 10.1016/J.Biopsych.2013.07.007  0.37
2013 Jarskog LF, Dong Z, Kangarlu A, Colibazzi T, Girgis RR, Kegeles LS, Barch DM, Buchanan RW, Csernansky JG, Goff DC, Harms MP, Javitt DC, Keefe RS, McEvoy JP, McMahon RP, et al. Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 1245-52. PMID 23325325 DOI: 10.1038/Npp.2013.23  0.415
2013 Ceaser A, Csernansky JG, Barch DM. COMT influences on prefrontal and striatal blood oxygenation level-dependent responses during working memory among individuals with schizophrenia, their siblings, and healthy controls. Cognitive Neuropsychiatry. 18: 257-83. PMID 23030509 DOI: 10.1080/13546805.2012.698100  0.42
2013 Selemon LD, Ceritoglu C, Ratnanather JT, Wang L, Harms MP, Aldridge K, Begović A, Csernansky JG, Miller MI, Rakic P. Distinct abnormalities of the primate prefrontal cortex caused by ionizing radiation in early or midgestation. The Journal of Comparative Neurology. 521: 1040-53. PMID 22911497 DOI: 10.1002/Cne.23217  0.351
2013 Harms MP, Wang L, Csernansky JG, Barch DM. Structure-function relationship of working memory activity with hippocampal and prefrontal cortex volumes. Brain Structure & Function. 218: 173-86. PMID 22362200 DOI: 10.1007/S00429-012-0391-8  0.397
2012 Aldridge K, Wang L, Harms MP, Moffitt AJ, Cole KK, Csernansky JG, Selemon LD. A longitudinal analysis of regional brain volumes in macaques exposed to X-irradiation in early gestation. Plos One. 7: e43109. PMID 22905212 DOI: 10.1371/Journal.Pone.0043109  0.374
2012 Turner JA, Calhoun VD, Michael A, van Erp TG, Ehrlich S, Segall JM, Gollub RL, Csernansky J, Potkin SG, Ho BC, Bustillo J, Schulz SC, FBIRN, Wang L. Heritability of multivariate gray matter measures in schizophrenia. Twin Research and Human Genetics : the Official Journal of the International Society For Twin Studies. 15: 324-35. PMID 22856368 DOI: 10.1017/Thg.2012.1  0.454
2012 Cobia DJ, Smith MJ, Wang L, Csernansky JG. Longitudinal progression of frontal and temporal lobe changes in schizophrenia. Schizophrenia Research. 139: 1-6. PMID 22647883 DOI: 10.1016/J.Schres.2012.05.002  0.714
2012 Karnik-Henry MS, Wang L, Barch DM, Harms MP, Campanella C, Csernansky JG. Medial temporal lobe structure and cognition in individuals with schizophrenia and in their non-psychotic siblings. Schizophrenia Research. 138: 128-35. PMID 22542243 DOI: 10.1016/J.Schres.2012.03.015  0.479
2012 Smith MJ, Horan WP, Karpouzian TM, Abram SV, Cobia DJ, Csernansky JG. Self-reported empathy deficits are uniquely associated with poor functioning in schizophrenia. Schizophrenia Research. 137: 196-202. PMID 22321668 DOI: 10.1016/J.Schres.2012.01.012  0.688
2012 Javitt DC, Buchanan RW, Keefe RS, Kern R, McMahon RP, Green MF, Lieberman J, Goff DC, Csernansky JG, McEvoy JP, Jarskog F, Seidman LJ, Gold JM, Kimhy D, Nolan KS, et al. Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia. Schizophrenia Research. 136: 25-31. PMID 22169248 DOI: 10.1016/J.Schres.2011.11.001  0.395
2012 Wang L, Fagan AM, Shah AR, Beg MF, Csernansky JG, Morris JC, Holtzman DM. Cerebrospinal fluid proteins predict longitudinal hippocampal degeneration in early-stage dementia of the Alzheimer type. Alzheimer Disease and Associated Disorders. 26: 314-21. PMID 22156755 DOI: 10.1097/Wad.0B013E31823C0Cf4  0.341
2012 Dong H, Murphy KM, Meng L, Montalvo-Ortiz J, Zeng Z, Kolber BJ, Zhang S, Muglia LJ, Csernansky JG. Corticotrophin releasing factor accelerates neuropathology and cognitive decline in a mouse model of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 28: 579-92. PMID 22045495 DOI: 10.3233/Jad-2011-111328  0.677
2012 Ceyhan E, Beg MF, CeritoÄŸlu C, Wang L, Morris JC, Csernansky JG, Miller MI, Ratnanather JT. Metric distances between hippocampal shapes indicate different rates of change over time in nondemented and demented subjects. Current Alzheimer Research. 9: 972-81. PMID 21875412 DOI: 10.2174/156720512803251138  0.327
2012 Wang L, Stern D, Cobia D, Reilly J, Csernansky J, Breiter H. Subtyping schizophrenia subjects using working memory and approach motivation neuroimaging markers F1000research. 3. DOI: 10.7490/F1000Research.1090765.1  0.689
2012 Smith MJ, Horan WP, Karpouzian T, Abram S, Cobia D, Csernansky JG. Poster #233 EMPATHY DEFICITS ARE UNIQUELY ASSOCIATED WITH POOR FUNCTIONING IN SCHIZOPHRENIA Schizophrenia Research. 136: S365. DOI: 10.1016/S0920-9964(12)71065-4  0.687
2011 Glick ID, Correll CU, Altamura AC, Marder SR, Csernansky JG, Weiden PJ, Leucht S, Davis JM. Mid-term and long-term efficacy and effectiveness of antipsychotic medications for schizophrenia: a data-driven, personalized clinical approach. The Journal of Clinical Psychiatry. 72: 1616-27. PMID 22244023 DOI: 10.4088/Jcp.11R06927  0.332
2011 Cobia DJ, Csernansky JG, Wang L. Cortical thickness in neuropsychologically near-normal schizophrenia. Schizophrenia Research. 133: 68-76. PMID 21981933 DOI: 10.1016/J.Schres.2011.08.017  0.71
2011 Smith MJ, Wang L, Cronenwett W, Goldman MB, Mamah D, Barch DM, Csernansky JG. Alcohol use disorders contribute to hippocampal and subcortical shape differences in schizophrenia. Schizophrenia Research. 131: 174-83. PMID 21658914 DOI: 10.1016/J.Schres.2011.05.014  0.452
2011 Zarow C, Wang L, Chui HC, Weiner MW, Csernansky JG. MRI shows more severe hippocampal atrophy and shape deformation in hippocampal sclerosis than in Alzheimer's disease. International Journal of Alzheimer's Disease. 2011: 483972. PMID 21547227 DOI: 10.4061/2011/483972  0.34
2011 Ceyhan E, Beg MF, Ceritoglu C, Wang L, Morris JC, Csernansky JG, Miller MI, Ratnanather JT. Quantization and analysis of hippocampal morphometric changes due to dementia of Alzheimer type using metric distances based on large deformation diffeomorphic metric mapping. Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society. 35: 275-93. PMID 21345652 DOI: 10.1016/J.Compmedimag.2011.01.005  0.318
2011 Csernansky JG, Smith MJ. Thought, feeling, and action in real time--monitoring of drug use in schizophrenia. The American Journal of Psychiatry. 168: 120-2. PMID 21297046 DOI: 10.1176/Appi.Ajp.2010.10111601  0.342
2011 Repovs G, Csernansky JG, Barch DM. Brain network connectivity in individuals with schizophrenia and their siblings. Biological Psychiatry. 69: 967-73. PMID 21193174 DOI: 10.1016/J.Biopsych.2010.11.009  0.406
2011 Buchanan RW, Keefe RS, Lieberman JA, Barch DM, Csernansky JG, Goff DC, Gold JM, Green MF, Jarskog LF, Javitt DC, Kimhy D, Kraus MS, McEvoy JP, Mesholam-Gately RI, Seidman LJ, et al. A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia. Biological Psychiatry. 69: 442-9. PMID 21145041 DOI: 10.1016/J.Biopsych.2010.09.052  0.39
2011 Goldman MB, Wang L, Wachi C, Daudi S, Csernansky J, Marlow-O'Connor M, Keedy S, Torres I. Structural pathology underlying neuroendocrine dysfunction in schizophrenia. Behavioural Brain Research. 218: 106-13. PMID 21093493 DOI: 10.1016/J.Bbr.2010.11.025  0.412
2011 Smith MJ, Wang L, Cronenwett W, Mamah D, Barch DM, Csernansky JG. Thalamic morphology in schizophrenia and schizoaffective disorder. Journal of Psychiatric Research. 45: 378-85. PMID 20797731 DOI: 10.1016/J.Jpsychires.2010.08.003  0.434
2011 Mamah D, Wang L, Csernansky J, Rice J, Barch DM. Morphometry of the amygdala, basal ganglia, hippocampus and thalamus in bipolar disorder and schizophrenia International Clinical Psychopharmacology. 26: e2-e3. DOI: 10.1097/01.Yic.0000405618.57707.De  0.429
2011 Reiter K, Csernansky J, Morris J, Wang L. P1-359: Cognitively normal individuals with Alzheimer's disease parents may be at risk for developing aging-related cortical thinning patterns characteristic of Alzheimer's disease Alzheimer's & Dementia. 7: S227-S228. DOI: 10.1016/J.Jalz.2011.05.639  0.31
2010 Cronenwett WJ, Csernansky J. Thalamic pathology in schizophrenia Current Topics in Behavioral Neurosciences. 4: 509-528. PMID 21312411 DOI: 10.1007/7854_2010_55  0.425
2010 Mamah D, Conturo TE, Harms MP, Akbudak E, Wang L, McMichael AR, Gado MH, Barch DM, Csernansky JG. Anterior thalamic radiation integrity in schizophrenia: a diffusion-tensor imaging study. Psychiatry Research. 183: 144-50. PMID 20619618 DOI: 10.1016/J.Pscychresns.2010.04.013  0.452
2010 Ceritoglu C, Wang L, Selemon LD, Csernansky JG, Miller MI, Ratnanather JT. Large Deformation Diffeomorphic Metric Mapping Registration of Reconstructed 3D Histological Section Images and in vivo MR Images. Frontiers in Human Neuroscience. 4: 43. PMID 20577633 DOI: 10.3389/Fnhum.2010.00043  0.32
2010 Mamah D, Wang L, Csernansky JG, Rice JP, Smith M, Barch DM. Morphometry of the hippocampus and amygdala in bipolar disorder and schizophrenia. Bipolar Disorders. 12: 341-3. PMID 20565442 DOI: 10.1111/J.1399-5618.2010.00802.X  0.421
2010 Karnik MS, Wang L, Barch DM, Morris JC, Csernansky JG. BDNF polymorphism rs6265 and hippocampal structure and memory performance in healthy control subjects. Psychiatry Research. 178: 425-9. PMID 20493546 DOI: 10.1016/J.Psychres.2009.09.008  0.767
2010 Harms MP, Wang L, Campanella C, Aldridge K, Moffitt AJ, Kuelper J, Ratnanather JT, Miller MI, Barch DM, Csernansky JG. Structural abnormalities in gyri of the prefrontal cortex in individuals with schizophrenia and their unaffected siblings. The British Journal of Psychiatry : the Journal of Mental Science. 196: 150-7. PMID 20118463 DOI: 10.1192/Bjp.Bp.109.067314  0.46
2010 Anticevic A, Repovs G, Van Snellenberg JX, Csernansky JG, Barch DM. Subcortical alignment precision in patients with schizophrenia. Schizophrenia Research. 120: 76-83. PMID 20097545 DOI: 10.1016/J.Schres.2009.12.040  0.424
2010 Wang L, Harms MP, Staggs JM, Xiong C, Morris JC, Csernansky JG, Galvin JE. Donepezil treatment and changes in hippocampal structure in very mild Alzheimer disease. Archives of Neurology. 67: 99-106. PMID 20065136 DOI: 10.1001/Archneurol.2009.292  0.375
2010 Marcus DS, Fotenos AF, Csernansky JG, Morris JC, Buckner RL. Open access series of imaging studies: longitudinal MRI data in nondemented and demented older adults. Journal of Cognitive Neuroscience. 22: 2677-84. PMID 19929323 DOI: 10.1162/Jocn.2009.21407  0.3
2010 Buchanan RW, Barch D, Csernansky J, Goff D, Gold J, Jarskog F, Javitt D, Keefe R, Lieberman J, McEvoy J, McMahon R, Marder S. MK-0777 FOR THE TREATMENT OF COGNITIVE IMPAIRMENTS IN PEOPLE WITH SCHIZOPHRENIA Schizophrenia Research. 117: 119. DOI: 10.1016/J.Schres.2010.02.053  0.373
2009 Lipkovich IA, Deberdt W, Csernansky JG, Sabbe B, Keefe RS, Kollack-Walker S. Relationships among neurocognition, symptoms and functioning in patients with schizophrenia: a path-analytic approach for associations at baseline and following 24 weeks of antipsychotic drug therapy. Bmc Psychiatry. 9: 44. PMID 19602273 DOI: 10.1186/1471-244X-9-44  0.393
2009 Qiu A, Wang L, Younes L, Harms MP, Ratnanather JT, Miller MI, Csernansky JG. Neuroanatomical asymmetry patterns in individuals with schizophrenia and their non-psychotic siblings. Neuroimage. 47: 1221-9. PMID 19481156 DOI: 10.1016/J.Neuroimage.2009.05.054  0.464
2009 Wang L, Khan A, Csernansky JG, Fischl B, Miller MI, Morris JC, Beg MF. Fully-automated, multi-stage hippocampus mapping in very mild Alzheimer disease. Hippocampus. 19: 541-8. PMID 19405129 DOI: 10.1002/Hipo.20616  0.307
2009 Chen LS, Rice TK, Thompson PA, Barch DM, Csernansky JG. Familial aggregation of clinical and neurocognitive features in sibling pairs with and without schizophrenia. Schizophrenia Research. 111: 159-66. PMID 19398304 DOI: 10.1016/J.Schres.2009.03.030  0.407
2009 Lieberman JA, Papadakis K, Csernansky J, Litman R, Volavka J, Jia XD, Gage A. A randomized, placebo-controlled study of memantine as adjunctive treatment in patients with schizophrenia Neuropsychopharmacology. 34: 1322-1329. PMID 19005465 DOI: 10.1038/Npp.2008.200  0.406
2009 Geller B, Harms MP, Wang L, Tillman R, DelBello MP, Bolhofner K, Csernansky JG. Effects of age, sex, and independent life events on amygdala and nucleus accumbens volumes in child bipolar I disorder. Biological Psychiatry. 65: 432-7. PMID 18990366 DOI: 10.1016/J.Biopsych.2008.09.033  0.361
2009 Smith MJ, Barch DM, Csernansky JG. Bridging the gap between schizophrenia and psychotic mood disorders: Relating neurocognitive deficits to psychopathology. Schizophrenia Research. 107: 69-75. PMID 18786811 DOI: 10.1016/J.Schres.2008.07.014  0.371
2009 Martin MV, Churchill JD, Dong H, Wozniak DF, Cheverud JM, Csernansky JG. Genetic influences on hippocampal structure and function in recombinant inbred mice. Behavioural Brain Research. 196: 78-83. PMID 18721828 DOI: 10.1016/J.Bbr.2008.07.029  0.375
2009 Wang L, Reiter K, Colvin M, Harms M, Csernansky J, Morris J. Effect of Scanner Field-Strength Upgrade on Reliability MRI Measurements of Cortical Volume, Area and Thickness Neuroimage. 47. DOI: 10.1016/S1053-8119(09)71914-7  0.302
2008 Lieberman JA, Bymaster FP, Meltzer HY, Deutch AY, Duncan GE, Marx CE, Aprille JR, Dwyer DS, Li XM, Mahadik SP, Duman RS, Porter JH, Modica-Napolitano JS, Newton SS, Csernansky JG. Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection. Pharmacological Reviews. 60: 358-403. PMID 18922967 DOI: 10.1124/Pr.107.00107  0.387
2008 Tepest R, Wang L, Csernansky JG, Neubert P, Heun R, Scheef L, Jessen F. Hippocampal surface analysis in subjective memory impairment, mild cognitive impairment and Alzheimer's dementia. Dementia and Geriatric Cognitive Disorders. 26: 323-9. PMID 18841017 DOI: 10.1159/000161057  0.343
2008 Wang L, Mamah D, Harms MP, Karnik M, Price JL, Gado MH, Thompson PA, Barch DM, Miller MI, Csernansky JG. Progressive deformation of deep brain nuclei and hippocampal-amygdala formation in schizophrenia. Biological Psychiatry. 64: 1060-8. PMID 18814865 DOI: 10.1016/J.Biopsych.2008.08.007  0.803
2008 Bonner-Jackson A, Yodkovik N, Csernansky JG, Barch DM. Episodic memory in schizophrenia: the influence of strategy use on behavior and brain activation. Psychiatry Research. 164: 1-15. PMID 18790618 DOI: 10.1016/J.Pscychresns.2007.12.012  0.396
2008 Smith MJ, Barch DM, Wolf TJ, Mamah D, Csernansky JG. Elevated rates of substance use disorders in non-psychotic siblings of individuals with schizophrenia. Schizophrenia Research. 106: 294-9. PMID 18774264 DOI: 10.1016/J.Schres.2008.07.015  0.359
2008 Smith MJ, Cloninger CR, Harms MP, Csernansky JG. Temperament and character as schizophrenia-related endophenotypes in non-psychotic siblings. Schizophrenia Research. 104: 198-205. PMID 18718739 DOI: 10.1016/J.Schres.2008.06.025  0.41
2008 Csernansky JG, Gillespie SK, Dierker DL, Anticevic A, Wang L, Barch DM, Van Essen DC. Symmetric abnormalities in sulcal patterning in schizophrenia. Neuroimage. 43: 440-6. PMID 18707008 DOI: 10.1016/J.Neuroimage.2008.07.034  0.457
2008 Calabrese DR, Wang L, Harms MP, Ratnanather JT, Barch DM, Cloninger CR, Thompson PA, Miller MI, Csernansky JG. Cingulate gyrus neuroanatomy in schizophrenia subjects and their non-psychotic siblings. Schizophrenia Research. 104: 61-70. PMID 18692994 DOI: 10.1016/J.Schres.2008.06.014  0.369
2008 Csernansky JG, Cronenwett WJ. Neural networks in schizophrenia. The American Journal of Psychiatry. 165: 937-9. PMID 18676594 DOI: 10.1176/Appi.Ajp.2008.08050700  0.335
2008 Smith MJ, Barch DM, Thompson PA, Csernansky JG. Subclinical expression of schizophrenia-like symptoms in non-psychotic siblings of individuals with schizophrenia. Schizophrenia Research. 103: 324-5. PMID 18550340 DOI: 10.1016/J.Schres.2008.04.028  0.402
2008 Anticevic A, Dierker DL, Gillespie SK, Repovs G, Csernansky JG, Van Essen DC, Barch DM. Comparing surface-based and volume-based analyses of functional neuroimaging data in patients with schizophrenia. Neuroimage. 41: 835-48. PMID 18434199 DOI: 10.1016/J.Neuroimage.2008.02.052  0.381
2008 Dong H, Yuede CM, Coughlan C, Lewis B, Csernansky JG. Effects of memantine on neuronal structure and conditioned fear in the Tg2576 mouse model of Alzheimer's disease. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 3226-36. PMID 18418360 DOI: 10.1038/Npp.2008.53  0.304
2008 Mamah D, Harms MP, Wang L, Barch D, Thompson P, Kim J, Miller MI, Csernansky JG. Basal ganglia shape abnormalities in the unaffected siblings of schizophrenia patients. Biological Psychiatry. 64: 111-20. PMID 18295189 DOI: 10.1016/J.Biopsych.2008.01.004  0.468
2008 Delawalla Z, Csernansky JG, Barch DM. Prefrontal cortex function in nonpsychotic siblings of individuals with schizophrenia. Biological Psychiatry. 63: 490-7. PMID 17631280 DOI: 10.1016/J.Biopsych.2007.05.007  0.422
2008 Csernansky J. Endophenotypes of psychosis Annals of General Psychiatry. 7. DOI: 10.1186/1744-859X-7-S1-S55  0.419
2008 Smith M, Barch D, Thompson P, Csernansky J. Erratum to ‘Letter to the Editor “Subclinical expression of schizophrenia-like symptoms in non-psychotic siblings of individuals with schizophrenia” [Schizophrenia Research 103 (2008) 324–325] Schizophrenia Research. 106: 374. DOI: 10.1016/J.Schres.2008.07.019  0.354
2008 Wang L, Murthi S, Miller JP, Gado MH, Miller MI, Morris JC, Csernansky JG. IC-P2-150: Comparing rates of change versus cross-sectional hippocampal measure in early DAT Alzheimer's & Dementia. 4: T66-T66. DOI: 10.1016/J.Jalz.2008.05.2604  0.363
2007 Harms MP, Wang L, Mamah D, Barch DM, Thompson PA, Csernansky JG. Thalamic shape abnormalities in individuals with schizophrenia and their nonpsychotic siblings. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 13835-42. PMID 18077695 DOI: 10.1523/Jneurosci.2571-07.2007  0.476
2007 John JP, Yashavantha BS, Gado M, Veena R, Jain S, Ravishankar S, Csernansky JG. A proposal for MRI-based parcellation of the frontal pole. Brain Structure & Function. 212: 245-53. PMID 17929054 DOI: 10.1007/S00429-007-0157-X  0.302
2007 Yuede CM, Dong H, Csernansky JG. Anti-dementia drugs and hippocampal-dependent memory in rodents. Behavioural Pharmacology. 18: 347-63. PMID 17762506 DOI: 10.1097/Fbp.0B013E3282Da278D  0.313
2007 Qiu A, Younes L, Wang L, Ratnanather JT, Gillepsie SK, Kaplan G, Csernansky J, Miller MI. Combining anatomical manifold information via diffeomorphic metric mappings for studying cortical thinning of the cingulate gyrus in schizophrenia. Neuroimage. 37: 821-33. PMID 17613251 DOI: 10.1016/J.Neuroimage.2007.05.007  0.368
2007 Barch DM, Csernansky JG. Abnormal parietal cortex activation during working memory in schizophrenia: verbal phonological coding disturbances versus domain-general executive dysfunction. The American Journal of Psychiatry. 164: 1090-8. PMID 17606661 DOI: 10.1176/Ajp.2007.164.7.1090  0.36
2007 Wang L, Hosakere M, Trein JC, Miller A, Ratnanather JT, Barch DM, Thompson PA, Qiu A, Gado MH, Miller MI, Csernansky JG. Abnormalities of cingulate gyrus neuroanatomy in schizophrenia. Schizophrenia Research. 93: 66-78. PMID 17433626 DOI: 10.1016/J.Schres.2007.02.021  0.455
2007 Wang L, Beg F, Ratnanather T, Ceritoglu C, Younes L, Morris JC, Csernansky JG, Miller MI. Large deformation diffeomorphism and momentum based hippocampal shape discrimination in dementia of the Alzheimer type. Ieee Transactions On Medical Imaging. 26: 462-70. PMID 17427733 DOI: 10.1109/Tmi.2006.887380  0.333
2007 Dong H, Martin MV, Colvin J, Ali Z, Wang L, Lu L, Williams RW, Rosen GD, Csernansky JG, Cheverud JM. Quantitative trait loci linked to thalamus and cortex gray matter volumes in BXD recombinant inbred mice. Heredity. 99: 62-9. PMID 17406662 DOI: 10.1038/Sj.Hdy.6800965  0.33
2007 Csernansky JG. Neurodegeneration in schizophrenia: evidence from in vivo neuroimaging studies. Thescientificworldjournal. 7: 135-43. PMID 17334606 DOI: 10.1100/Tsw.2007.47  0.406
2007 Bonner-Jackson A, Csernansky JG, Barch DM. Levels-of-processing effects in first-degree relatives of individuals with schizophrenia. Biological Psychiatry. 61: 1141-7. PMID 17123479 DOI: 10.1016/J.Biopsych.2006.07.006  0.433
2007 Mamah D, Wang L, Barch D, de Erausquin GA, Gado M, Csernansky JG. Structural analysis of the basal ganglia in schizophrenia. Schizophrenia Research. 89: 59-71. PMID 17071057 DOI: 10.1016/J.Schres.2006.08.031  0.464
2007 Lipkovich I, Deberdt W, Csernansky JG, Buckley P, Peuskens J, Kollack-Walker S, Zhang Y, Liu-Seifert H, Houston JP. Predictors of risk for relapse in patients with schizophrenia or schizoaffective disorder during olanzapine drug therapy. Journal of Psychiatric Research. 41: 305-10. PMID 17010994 DOI: 10.1016/J.Jpsychires.2006.07.016  0.334
2006 Csernansky JG, Dong H, Fagan AM, Wang L, Xiong C, Holtzman DM, Morris JC. Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia. The American Journal of Psychiatry. 163: 2164-9. PMID 17151169 DOI: 10.1176/Ajp.2006.163.12.2164  0.33
2006 John JP, Wang L, Moffitt AJ, Singh HK, Gado MH, Csernansky JG. Inter-rater reliability of manual segmentation of the superior, inferior and middle frontal gyri. Psychiatry Research. 148: 151-63. PMID 17088050 DOI: 10.1016/J.Pscychresns.2006.05.006  0.378
2006 Brahmbhatt SB, Haut K, Csernansky JG, Barch DM. Neural correlates of verbal and nonverbal working memory deficits in individuals with schizophrenia and their high-risk siblings. Schizophrenia Research. 87: 191-204. PMID 16842976 DOI: 10.1016/J.Schres.2006.05.019  0.411
2006 Delawalla Z, Barch DM, Fisher Eastep JL, Thomason ES, Hanewinkel MJ, Thompson PA, Csernansky JG. Factors mediating cognitive deficits and psychopathology among siblings of individuals with schizophrenia. Schizophrenia Bulletin. 32: 525-37. PMID 16714471 DOI: 10.1093/Schbul/Sbj082  0.375
2006 Csernansky JG, Martin MV, Czeisler B, Meltzer MA, Ali Z, Dong H. Neuroprotective effects of olanzapine in a rat model of neurodevelopmental injury. Pharmacology, Biochemistry, and Behavior. 83: 208-13. PMID 16524622 DOI: 10.1016/J.Pbb.2006.01.009  0.393
2006 Andrews J, Wang L, Csernansky JG, Gado MH, Barch DM. Abnormalities of thalamic activation and cognition in schizophrenia. The American Journal of Psychiatry. 163: 463-9. PMID 16513868 DOI: 10.1176/Appi.Ajp.163.3.463  0.47
2006 Wang L, Miller JP, Gado MH, McKeel DW, Rothermich M, Miller MI, Morris JC, Csernansky JG. Abnormalities of hippocampal surface structure in very mild dementia of the Alzheimer type. Neuroimage. 30: 52-60. PMID 16243546 DOI: 10.1016/J.Neuroimage.2005.09.017  0.347
2006 Csernansky J. Neuroanatomical markers of early Alzheimer's disease Annals of General Psychiatry. 5. DOI: 10.1186/1744-859X-5-S1-S33  0.306
2006 Csernansky J. Improving the long term outcome of schizophrenia Annals of General Psychiatry. 5. DOI: 10.1186/1744-859X-5-S1-S28  0.398
2006 Csernansky JG, Dong H, Fagan AM, Wang L, Xiong C, Holtzman DM, Morris JC. Plasma Cortisol and Progression of Dementia in DAT Subjects American Journal of Psychiatry. 163: 2164. DOI: 10.1176/Appi.Ajp.163.12.2164  0.336
2005 Csernansky JG, Wang L, Miller JP, Galvin JE, Morris JC. Neuroanatomical predictors of response to donepezil therapy in patients with dementia. Archives of Neurology. 62: 1718-22. PMID 16286546 DOI: 10.1001/Archneur.62.11.1718  0.35
2005 Martin MV, Dong H, Bertchume A, Csernansky JG. Low dose quetiapine reverses deficits in contextual and cued fear conditioning in rats with excitotoxin-induced hippocampal neuropathy. Pharmacology, Biochemistry, and Behavior. 82: 263-9. PMID 16183107 DOI: 10.1016/J.Pbb.2005.08.010  0.368
2005 Bonner-Jackson A, Haut K, Csernansky JG, Barch DM. The influence of encoding strategy on episodic memory and cortical activity in schizophrenia. Biological Psychiatry. 58: 47-55. PMID 15992522 DOI: 10.1016/J.Biopsych.2005.05.011  0.417
2005 Csernansky JG, Martin M, Shah R, Bertchume A, Colvin J, Dong H. Cholinesterase inhibitors ameliorate behavioral deficits induced by MK-801 in mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 2135-43. PMID 15956997 DOI: 10.1038/Sj.Npp.1300761  0.368
2005 Csernansky JG, Wang L, Swank J, Miller JP, Gado M, McKeel D, Miller MI, Morris JC. Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly. Neuroimage. 25: 783-92. PMID 15808979 DOI: 10.1016/J.Neuroimage.2004.12.036  0.355
2005 Dong H, Csernansky CA, Martin MV, Bertchume A, Vallera D, Csernansky JG. Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer's disease. Psychopharmacology. 181: 145-52. PMID 15778881 DOI: 10.1007/S00213-005-2230-6  0.305
2005 Selemon LD, Wang L, Nebel MB, Csernansky JG, Goldman-Rakic PS, Rakic P. Direct and indirect effects of fetal irradiation on cortical gray and white matter volume in the macaque. Biological Psychiatry. 57: 83-90. PMID 15607304 DOI: 10.1016/J.Biopsych.2004.10.014  0.389
2005 Wang L, Miller JP, Gado MH, McKeel D, Miller MI, Morris JC, Csernansky JG. [P-136]: Hippocampal shape abnormalities in early AD: A replication study Alzheimer's & Dementia. 1: S52-S53. DOI: 10.1016/J.Jalz.2005.06.209  0.318
2004 Ratnanather JT, Wang L, Nebel MB, Hosakere M, Han X, Csernansky JG, Miller MI. Validation of semiautomated methods for quantifying cingulate cortical metrics in schizophrenia. Psychiatry Research. 132: 53-68. PMID 15546703 DOI: 10.1016/J.Pscychresns.2004.07.003  0.345
2004 Csernansky JG, Wang L, Joshi SC, Ratnanather JT, Miller MI. Computational anatomy and neuropsychiatric disease: probabilistic assessment of variation and statistical inference of group difference, hemispheric asymmetry, and time-dependent change. Neuroimage. 23: S56-68. PMID 15501101 DOI: 10.1016/J.Neuroimage.2004.07.025  0.377
2004 Hogan RE, Wang L, Bertrand ME, Willmore LJ, Bucholz RD, Nassif AS, Csernansky JG. MRI-based high-dimensional hippocampal mapping in mesial temporal lobe epilepsy. Brain : a Journal of Neurology. 127: 1731-40. PMID 15231583 DOI: 10.1093/Brain/Awh197  0.377
2004 Csernansky JG, Schindler MK, Splinter NR, Wang L, Gado M, Selemon LD, Rastogi-Cruz D, Posener JA, Thompson PA, Miller MI. Abnormalities of thalamic volume and shape in schizophrenia. The American Journal of Psychiatry. 161: 896-902. PMID 15121656 DOI: 10.1176/Appi.Ajp.161.5.896  0.47
2004 Heydebrand G, Weiser M, Rabinowitz J, Hoff AL, DeLisi LE, Csernansky JG. Correlates of cognitive deficits in first episode schizophrenia. Schizophrenia Research. 68: 1-9. PMID 15037334 DOI: 10.1016/S0920-9964(03)00097-5  0.417
2004 Csernansky JG, Wang L, Miller JP, Gado M, McKeel D, Miller MI, Morris JC. P2-166 Hippocampal shape and volume predicts the onset of dementia in the elderly Neurobiology of Aging. 25: S273. DOI: 10.1016/S0197-4580(04)80913-8  0.313
2003 Miller MI, Hosakere M, Barker AR, Priebe CE, Lee N, Ratnanather JT, Wang L, Gado M, Morris JC, Csernansky JG. Labeled cortical mantle distance maps of the cingulate quantify differences between dementia of the Alzheimer type and healthy aging. Proceedings of the National Academy of Sciences of the United States of America. 100: 15172-7. PMID 14657370 DOI: 10.1073/Pnas.2136624100  0.368
2003 Tepest R, Wang L, Miller MI, Falkai P, Csernansky JG. Hippocampal deformities in the unaffected siblings of schizophrenia subjects. Biological Psychiatry. 54: 1234-40. PMID 14643091 DOI: 10.1016/S0006-3223(03)00702-9  0.458
2003 Barch DM, Mathews JR, Buckner RL, Maccotta L, Csernansky JG, Snyder AZ. Hemodynamic responses in visual, motor, and somatosensory cortices in schizophrenia. Neuroimage. 20: 1884-93. PMID 14642498 DOI: 10.1016/S1053-8119(03)00449-X  0.396
2003 Wang L, Swank JS, Glick IE, Gado MH, Miller MI, Morris JC, Csernansky JG. Changes in hippocampal volume and shape across time distinguish dementia of the Alzheimer type from healthy aging. Neuroimage. 20: 667-82. PMID 14568443 DOI: 10.1016/S1053-8119(03)00361-6  0.373
2003 Dong H, Csernansky CA, Chu Y, Csernansky JG. Intracerebroventricular kainic acid administration to neonatal rats alters interneuron development in the hippocampus. Brain Research. Developmental Brain Research. 145: 81-92. PMID 14519496 DOI: 10.1016/S0165-3806(03)00216-5  0.308
2003 Csernansky JG. Treatment of schizophrenia: preventing the progression of disease. The Psychiatric Clinics of North America. 26: 367-79. PMID 12778839 DOI: 10.1016/S0193-953X(02)00113-2  0.372
2003 Bardgett ME, Boeckman R, Krochmal D, Fernando H, Ahrens R, Csernansky JG. NMDA receptor blockade and hippocampal neuronal loss impair fear conditioning and position habit reversal in C57Bl/6 mice. Brain Research Bulletin. 60: 131-42. PMID 12725901 DOI: 10.1016/S0361-9230(03)00023-6  0.635
2003 Barch DM, Sheline YI, Csernansky JG, Snyder AZ. Working memory and prefrontal cortex dysfunction: specificity to schizophrenia compared with major depression. Biological Psychiatry. 53: 376-84. PMID 12614990 DOI: 10.1016/S0006-3223(02)01674-8  0.366
2003 Posener JA, Wang L, Price JL, Gado MH, Province MA, Miller MI, Babb CM, Csernansky JG. High-dimensional mapping of the hippocampus in depression. The American Journal of Psychiatry. 160: 83-9. PMID 12505805 DOI: 10.1176/Appi.Ajp.160.1.83  0.358
2003 Splinter N, Wang L, Schindler M, Selemon L, Miller M, Csernansky J. Volume and shape abnormalities of the thalamus in schizophrenia subjects Schizophrenia Research. 60: 207. DOI: 10.1016/S0920-9964(03)81149-0  0.345
2002 Bardgett ME, Humphrey WM, Csernansky JG. The effects of excitotoxic hippocampal lesions in rats on risperidone- and olanzapine-induced locomotor suppression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 27: 930-8. PMID 12464450 DOI: 10.1016/S0893-133X(02)00376-7  0.653
2002 Csernansky JG, Wang L, Jones D, Rastogi-Cruz D, Posener JA, Heydebrand G, Miller JP, Miller MI. Hippocampal deformities in schizophrenia characterized by high dimensional brain mapping. The American Journal of Psychiatry. 159: 2000-6. PMID 12450948 DOI: 10.1176/Appi.Ajp.159.12.2000  0.486
2002 Barch DM, Csernansky JG, Conturo T, Snyder AZ. Working and long-term memory deficits in schizophrenia: is there a common prefrontal mechanism? Journal of Abnormal Psychology. 111: 478-94. PMID 12150424 DOI: 10.1037/0021-843X.111.3.478  0.381
2002 Csernansky JG, Schuchart EK. Relapse and rehospitalisation rates in patients with schizophrenia: effects of second generation antipsychotics. Cns Drugs. 16: 473-84. PMID 12056922 DOI: 10.2165/00023210-200216070-00004  0.361
2002 Schindler MK, Wang L, Selemon LD, Goldman-Rakic PS, Rakic P, Csernansky JG. Abnormalities of thalamic volume and shape detected in fetally irradiated rhesus monkeys with high dimensional brain mapping. Biological Psychiatry. 51: 827-37. PMID 12007457 DOI: 10.1016/S0006-3223(01)01341-5  0.391
2002 Yin H, Bardgett ME, Csernansky JG. Kainic acid lesions disrupt fear-mediated memory processing. Neurobiology of Learning and Memory. 77: 389-401. PMID 11991765 DOI: 10.1006/Nlme.2001.4037  0.631
2002 Curtin F, Stalman SLP, Lieberman J, Schneider L, Csernansky JG, Mahmoud R. Prevention of relapse in schizophrenia [2] (multiple letters) New England Journal of Medicine. 346: 1412-1413. PMID 11987323 DOI: 10.1056/Nejm200205023461816  0.385
2002 Csernansky JG, Mahmoud R, Brenner R. A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia. The New England Journal of Medicine. 346: 16-22. PMID 11777998 DOI: 10.1056/Nejmoa002028  0.38
2002 Velligan DI, Newcomer J, Pultz J, Csernansky J, Hoff AL, Mahurin R, Miller AL. Does cognitive function improve with quetiapine in comparison to haloperidol? Schizophrenia Research. 53: 239-48. PMID 11738537 DOI: 10.1016/S0920-9964(01)00268-7  0.367
2002 Csernansky JG, Bardgett ME, Dong H, Humphrey W, Wang L. Hippocampal structure and the action of cholinomimetic drugs Drug Development Research. 56: 531-540. DOI: 10.1002/Ddr.10106  0.665
2001 Buckley P, Miller AL, Olsen J, Garver D, Miller DD, Csernansky J. When symptoms persist: clozapine augmentation strategies. Schizophrenia Bulletin. 27: 615-628. PMID 11824488 DOI: 10.1093/Oxfordjournals.Schbul.A006901  0.302
2001 Wang L, Joshi SC, Miller MI, Csernansky JG. Statistical analysis of hippocampal asymmetry in schizophrenia. Neuroimage. 14: 531-45. PMID 11506528 DOI: 10.1006/Nimg.2001.0830  0.424
2001 Hoff AL, Kremen WS, Wieneke MH, Lauriello J, Blankfeld HM, Faustman WO, Csernansky JG, Nordahl TE. Association of estrogen levels with neuropsychological performance in women with schizophrenia. The American Journal of Psychiatry. 158: 1134-9. PMID 11431236 DOI: 10.1176/Appi.Ajp.158.7.1134  0.397
2001 Humphrey WM, Bardgett ME, Montgomery EM, Taylor GT, Csernansky JG. Methods for inducing neuronal loss in preweanling rats using intracerebroventricular infusion of kainic acid. Brain Research. Brain Research Protocols. 7: 1-10. PMID 11275518 DOI: 10.1016/S1385-299X(00)00055-6  0.724
2001 Tepest R, Wang L, Falkai P, Csernansky JG. Shape analysis of the hippocampus formation in schizophrenics and their healthy siblings Neuroimage. 13: 265. DOI: 10.1016/S1053-8119(01)91608-8  0.359
2000 Csernansky JG, Wang L, Joshi S, Miller JP, Gado M, Kido D, McKeel D, Morris JC, Miller MI. Early DAT is distinguished from aging by high-dimensional mapping of the hippocampus. Dementia of the Alzheimer type. Neurology. 55: 1636-43. PMID 11113216 DOI: 10.1212/Wnl.55.11.1636  0.375
2000 Hoff AL, Sakuma M, Razi K, Heydebrand G, Csernansky JG, DeLisi LE. Lack of association between duration of untreated illness and severity of cognitive and structural brain deficits at the first episode of schizophrenia. The American Journal of Psychiatry. 157: 1824-8. PMID 11058480 DOI: 10.1176/Appi.Ajp.157.11.1824  0.438
2000 Leeman B, Barch D, Snyder A, Csernansky J, Ollinger J, McAvoy M, Raichle M. Medial parietal cortex: Functional properties in normal subjects and schizophrenic patients Neuroimage. 11: S202. DOI: 10.1016/S1053-8119(00)91135-2  0.303
2000 Barch D, Csernansky J, Snyder A, Conturo T. Dorsolateral prefrontal cortex dysfunction in schizophrenia: Relationship to both working memory and long term memory Neuroimage. 11: S193. DOI: 10.1016/S1053-8119(00)91126-1  0.345
2000 Csernansky J, Okamoto A. 104. Risperidone vs haloperidol for relapse prevention in schizophrenia and schizoaffective disorder: a long-term double-blind comparison Biological Psychiatry. 47: S31-S32. DOI: 10.1016/S0006-3223(00)00366-8  0.362
1999 Taylor G, Bardgett M, Csernansky J, Early T, Haller J, Scherrer J, Womack S. Neuroleptic influences on a lateralized behavioral bias in unoperated rats Psychopharmacology. 144: 30-37. PMID 10379621 DOI: 10.1007/S002130050973  0.737
1999 Montgomery EM, Bardgett ME, Lall B, Csernansky CA, Csernansky JG. Delayed neuronal loss after administration of intracerebroventricular kainic acid to preweanling rats. Brain Research. Developmental Brain Research. 112: 107-16. PMID 9974164 DOI: 10.1016/S0165-3806(98)00161-8  0.645
1999 Faustman WO, Bardgett M, Faull KF, Pfefferbaum A, Csernansky JG. Cerebrospinal fluid glutamate inversely correlates with positive symptom severity in unmedicated male schizophrenic/schizoaffective patients. Biological Psychiatry. 45: 68-75. PMID 9894577 DOI: 10.1016/S0006-3223(98)00207-8  0.662
1999 Marsh L, Lim KO, Hoff AL, Harris D, Beal M, Minn K, Faustman WO, Csernansky JG, Sullivan EV, Pfefferbaum A. Severity of schizophrenia and magnetic resonance imaging abnormalities: a comparison of state and veterans hospital patients. Biological Psychiatry. 45: 49-61. PMID 9894575 DOI: 10.1016/S0006-3223(98)00197-8  0.409
1998 Csernansky JG, Csernansky CA, Kogelman L, Montgomery EM, Bardgett ME. Progressive neurodegeneration after intracerebroventricular kainic acid administration in rats: implications for schizophrenia? Biological Psychiatry. 44: 1143-50. PMID 9836017 DOI: 10.1016/S0006-3223(98)00019-5  0.666
1998 Csernansky JG, Joshi S, Wang L, Haller JW, Gado M, Miller JP, Grenander U, Miller MI. Hippocampal morphometry in schizophrenia by high dimensional brain mapping. Proceedings of the National Academy of Sciences of the United States of America. 95: 11406-11. PMID 9736749 DOI: 10.1073/Pnas.95.19.11406  0.485
1998 Roe DL, Bardgett ME, Csernansky CA, Csernansky JG. Induction of Fos protein by antipsychotic drugs in rat brain following kainic acid-induced limbic-cortical neuronal loss. Psychopharmacology. 138: 151-8. PMID 9718284 DOI: 10.1007/S002130050657  0.678
1998 Newcomer JW, Craft S, Askins K, Hershey T, Bardgett ME, Csernansky JG, Gagliardi AE, Vogler G. Glucocorticoid interactions with memory function in schizophrenia. Psychoneuroendocrinology. 23: 65-72. PMID 9618753 DOI: 10.1016/S0306-4530(97)00081-4  0.684
1998 Csernansky JG, Bardgett ME. Limbic-cortical neuronal damage and the pathophysiology of schizophrenia. Schizophrenia Bulletin. 24: 231-48. PMID 9613623 DOI: 10.1093/Oxfordjournals.Schbul.A033323  0.692
1998 Csernansky JG, Grace AA. New models of the pathophysiology of schizophrenia: editors' introduction. Schizophrenia Bulletin. 24: 185-7. PMID 9613619 DOI: 10.1093/Oxfordjournals.Schbul.A033319  0.382
1998 Bardgett ME, Jackson JL, Taylor BM, Csernansky JG. The effects of kainic acid lesions on locomotor responses to haloperidol and clozapine. Psychopharmacology. 135: 270-8. PMID 9498730 DOI: 10.1007/S002130050509  0.654
1998 Sheline YI, Miller K, Bardgett ME, Csernansky JG. Higher cerebrospinal fluid MHPG in subjects with dementia of the Alzheimer type: Relationship with cognitive dysfunction American Journal of Geriatric Psychiatry. 6: 155-161. DOI: 10.1097/00019442-199805000-00009  0.584
1997 Marsh L, Harris D, Lim KO, Beal M, Hoff AL, Minn K, Csernansky JG, DeMent S, Faustman WO, Sullivan EV, Pfefferbaum A. Structural magnetic resonance imaging abnormalities in men with severe chronic schizophrenia and an early age at clinical onset. Archives of General Psychiatry. 54: 1104-12. PMID 9400346 DOI: 10.1001/Archpsyc.1997.01830240060009  0.4
1997 Bardgett ME, Salaris SL, Jackson JL, Harding J, Csernansky JG. The effects of kainic acid lesions on dopaminergic responses to haloperidol and clozapine. Psychopharmacology. 133: 142-51. PMID 9342780 DOI: 10.1007/S002130050384  0.651
1997 Bardgett ME, Jacobs PS, Jackson JL, Csernansky JG. Kainic acid lesions enhance locomotor responses to novelty, saline, amphetamine, and MK-801. Behavioural Brain Research. 84: 47-55. PMID 9079771 DOI: 10.1016/S0166-4328(96)00132-5  0.654
1997 Sheline Y, Bardgett ME, Csernansky JG. Correlated reductions in cerebrospinal fluid 5-HIAA and MHPG concentrations after treatment with selective serotonin reuptake inhibitors. Journal of Clinical Psychopharmacology. 17: 11-4. PMID 9004051 DOI: 10.1097/00004714-199702000-00003  0.633
1997 Marsh L, Lim K, Hoff A, Harris D, Beal M, Minn K, Faustman W, Csernansky J, Sullivan E, Pfefferbaum A. Strucrural MRI abnormalities in schizophrenia: A comparison of state hospital and veterans hospital patients Schizophrenia Research. 24: 152. DOI: 10.1016/S0920-9964(97)82434-6  0.314
1997 Csernansky JG, Haller JW, Banerjee A, Wang L, Joshi S, Christensen GE, Gado M, Vannier MW, Miller MI. A comparison of the hippocampus in schizophrenia and control subjects using automated methods for neuromorphometry Schizophrenia Research. 24: 141. DOI: 10.1016/S0920-9964(97)82403-6  0.437
1997 Montgomery EE, Bardgett ME, Csernansky JG. Limbic-cortical neuropathology in rats: A developmental study Schizophrenia Research. 24: 28. DOI: 10.1016/S0920-9964(97)82080-4  0.623
1996 Hoff AL, Faustman WO, Wieneke M, Espinoza S, Costa M, Wolkowitz O, Csernansky JG. The effects of clozapine on symptom reduction, neurocognitive function, and clinical management in treatment-refractory state hospital schizophrenic inpatients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 15: 361-9. PMID 8887990 DOI: 10.1016/0893-133X(95)00242-6  0.329
1996 Hoff AL, Harris D, Faustman WO, Beal M, DeVilliers D, Mone RD, Moses JA, Csernansky JG. A neuropsychological study of early onset schizophrenia. Schizophrenia Research. 20: 21-8. PMID 8794490 DOI: 10.1016/0920-9964(95)00065-8  0.354
1996 Lim KO, Harris D, Beal M, Hoff AL, Minn K, Csernansky JG, Faustman WO, Marsh L, Sullivan EV, Pfefferbaum A. Gray matter deficits in young onset schizophrenia are independent of age of onset. Biological Psychiatry. 40: 4-13. PMID 8780849 DOI: 10.1016/0006-3223(95)00356-8  0.364
1996 Taylor G, Bardgett M, Csernansky J, Early T, Haller J, Scherrer J, Womack S. Male reproductive systems under chronic fluoxetine or trimipramine treatment. Physiology & Behavior. 59: 479-85. PMID 8700950 DOI: 10.1016/0031-9384(95)02088-8  0.72
1996 Csernansky JG, Bardgett ME, Sheline YI, Morris JC, Olney JW. CSF excitatory amino acids and severity of illness in Alzheimer's disease. Neurology. 46: 1715-20. PMID 8649576 DOI: 10.1212/Wnl.46.6.1715  0.635
1996 Haller JW, Christensen GE, Joshi SC, Newcomer JW, Miller MI, Csernansky JG, Vannier MW. Hippocampal MR imaging morphometry by means of general pattern matching. Radiology. 199: 787-91. PMID 8638006 DOI: 10.1148/Radiology.199.3.8638006  0.328
1996 Bardgett M, Csernansky J. Neurodegeneration in schizophrenia: A possible animal model? Biological Psychiatry. 39: 611-612. DOI: 10.1016/0006-3223(96)84322-8  0.65
1996 Bardgett ME, Csernansky JG. Antipsychotic Drug Action After Lesions to the Hippocampus or Frontal Cortex Handbook of Experimental Pharmacology. 120: 267-288. DOI: 10.1007/978-3-642-61007-3_9  0.686
1995 Nelson EC, Sheline YI, Bardgett ME, Jackson JL, Csernansky JG. Platelet paroxetine binding in major depressive disorder with and without comorbid obsessive-compulsive disorder. Psychiatry Research. 58: 117-25. PMID 8570763 DOI: 10.1016/0165-1781(95)02695-S  0.622
1995 Bardgett ME, Jackson JL, Taylor GT, Csernansky JG. Kainic acid decreases hippocampal neuronal number and increases dopamine receptor binding in the nucleus accumbens: an animal model of schizophrenia. Behavioural Brain Research. 70: 153-64. PMID 8561906 DOI: 10.1016/0166-4328(95)80005-0  0.755
1995 Sheline YI, Bardgett ME, Jackson JL, Newcomer JW, Csernansky JG. Platelet serotonin markers and depressive symptomatology. Biological Psychiatry. 37: 442-7. PMID 7786957 DOI: 10.1016/0006-3223(94)00160-5  0.619
1995 Sheline YI, Black KJ, Bardgett ME, Csernansky JG. Platelet binding characteristics distinguish placebo responders from nonresponders in depression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 12: 315-22. PMID 7576008 DOI: 10.1016/0893-133X(94)00097-J  0.615
1995 Faustman WO, Ringo DL, Lauriello J, Lim KO, Pfefferbaum A, Bardgett ME, Csernansky JG. Effects of seroquel™ (ICI 204636) on platelet serotonin-2 binding in schizophrenia Schizophrenia Research. 15: 149-150. DOI: 10.1016/0920-9964(95)95464-K  0.665
1995 Bardgett ME, Jackson JL, Csernansky JG. Schizophrenia-like hippocampal neuropathy in rats: Changes in accumbens core and shell dopamine after haloperidol treatment Schizophrenia Research. 15: 142-143. DOI: 10.1016/0920-9964(95)95442-C  0.682
1994 Bardgett ME, Taylor GT, Csernansky JG, Newcomer JW, Nock B. Chronic corticosterone treatment impairs spontaneous alternation behavior in rats. Behavioral and Neural Biology. 61: 186-90. PMID 8204085 DOI: 10.1016/S0163-1047(05)80074-3  0.724
1994 Zipursky RB, Marsh L, Lim KO, DeMent S, Shear PK, Sullivan EV, Murphy GM, Csernansky JG, Pfefferbaum A. Volumetric MRI assessment of temporal lobe structures in schizophrenia. Biological Psychiatry. 35: 501-16. PMID 8038294 DOI: 10.1016/0006-3223(94)90097-3  0.365
1994 Ford JM, White PM, Csernansky JG, Faustman WO, Roth WT, Pfefferbaum A. ERPs in schizophrenia: effects of antipsychotic medication. Biological Psychiatry. 36: 153-70. PMID 7948453 DOI: 10.1016/0006-3223(94)91221-1  0.316
1994 Csernansky JG, Newcomer JW. Are there neurochemical indicators of risk for schizophrenia? Schizophrenia Bulletin. 20: 75-88. PMID 7910978 DOI: 10.1093/Schbul/20.1.75  0.398
1994 Lim K, Harris D, Beal M, Minn K, Hoff A, Csernansky J, Faustman W, Marsh L, Sullivan E, Pfefferbaum A. Brain volume abnormalities in schizophrenia are not related to age of onset Biological Psychiatry. 35: 719. DOI: 10.1016/0006-3223(94)91032-4  0.397
1993 Bardgett ME, Wrona CT, Newcomer JW, Csernansky JG. Subcortical excitatory amino acid levels after acute and subchronic administration of typical and atypical neuroleptics. European Journal of Pharmacology. 230: 245-50. PMID 8095021 DOI: 10.1016/0014-2999(93)90557-X  0.647
1993 Csernansky JG, Wrona CT, Bardgett ME, Early TS, Newcomer JW. Subcortical dopamine and serotonin turnover during acute and subchronic administration of typical and atypical neuroleptics. Psychopharmacology. 110: 145-51. PMID 7870875 DOI: 10.1007/Bf02246964  0.64
1993 Newcomer J, Craft S, Askins K, Hershey T, Bardgett M, Csernansky J. Insensitivity to dexamethasone-induced declarative memory deficits in patients with schizophrenia Schizophrenia Research. 9: 245-246. DOI: 10.1016/0920-9964(93)90552-T  0.679
1993 Bardgett M, Wrona C, Newcomer J, Csernansky J. The effects of intracerebroventricular kainic acid administration on forebrain neurochemistry Schizophrenia Research. 9: 146. DOI: 10.1016/0920-9964(93)90253-F  0.607
1992 Hewlett WA, Vinogradov S, Martin K, Berman S, Csernansky JG. Fenfluramine stimulation of prolactin in obsessive-compulsive disorder. Psychiatry Research. 42: 81-92. PMID 1603884 DOI: 10.1016/0165-1781(92)90041-Z  0.302
1992 Newcomer JW, Riney SJ, Vinogradov S, Csernansky JG. Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements during maintenance haloperidol treatment in male patients with schizophrenia. Psychiatry Research. 41: 191-202. PMID 1594706 DOI: 10.1016/0165-1781(92)90001-J  0.308
1992 Newcomer JW, Faustman WO, Zipursky RB, Csernansky JG. Zacopride in schizophrenia: a single-blind serotonin type 3 antagonist trial. Archives of General Psychiatry. 49: 751-2. PMID 1514881 DOI: 10.1001/Archpsyc.1992.01820090079013  0.361
1992 Faustman WO, Bono MA, Moses JA, Csernansky JG. Season of birth and neuropsychological impairment in schizophrenia. The Journal of Nervous and Mental Disease. 180: 644-8. PMID 1402843 DOI: 10.1097/00005053-199210000-00006  0.386
1992 Whiteford HA, Stedman TJ, Welham J, Csernansky JG, Pond SM. Placebo-controlled, double-blind study of the effects of proglumide in the treatment of schizophrenia. Journal of Clinical Psychopharmacology. 12: 337-40. PMID 1362205 DOI: 10.1097/00004714-199210000-00008  0.359
1991 Newcomer JW, Faustman WO, Whiteford HA, Moses JA, Csernansky JG. Symptomatology and cognitive impairment associate independently with post-dexamethasone cortisol concentrations in unmedicated schizophrenic patients. Biological Psychiatry. 29: 855-64. PMID 2049484 DOI: 10.1016/0006-3223(91)90052-N  0.322
1991 Csernansky JG, Murphy GM, Faustman WO. Limbic/mesolimbic connections and the pathogenesis of schizophrenia. Biological Psychiatry. 30: 383-400. PMID 1912130 DOI: 10.1016/0006-3223(91)90295-W  0.387
1990 Csernansky JG, Bellows EP, Barnes DE, Lombrozo L. Sensitization versus tolerance to the dopamine turnover-elevating effects of haloperidol: the effect of regular/intermittent dosing. Psychopharmacology. 101: 519-24. PMID 2388975 DOI: 10.1007/Bf02244231  0.3
1990 Newcomer JW, Faustman WO, Yeh W, Csernansky JG. Distinguishing depression and negative symptoms in unmedicated patients with schizophrenia. Psychiatry Research. 31: 243-50. PMID 2333356 DOI: 10.1016/0165-1781(90)90093-K  0.301
1990 Csernansky JG, Barnes DE, Bellows EP, Lombrozo L. Interrelationships between plasma homovanillic acid and indices of dopamine turnover in multiple brain areas during haloperidol and saline administration. Life Sciences. 46: 707-13. PMID 2314192 DOI: 10.1016/0024-3205(90)90076-4  0.311
1990 Petrie EC, Faustman WO, Moses JA, Lombrozo L, Csernansky JG. Correlates of rapid neuroleptic response in male patients with schizophrenia. Psychiatry Research. 33: 171-7. PMID 2243894 DOI: 10.1016/0165-1781(90)90071-C  0.351
1990 Warner MD, Peabody CA, Csernansky JG. Olfactory functioning in schizophrenia and depression. Biological Psychiatry. 27: 457-8. PMID 2178695 DOI: 10.1016/0006-3223(90)90557-I  0.341
1990 Csernansky JG, King RJ, Faustman WO, Moses JA, Poscher ME, Faull KF. 5-HIAA in cerebrospinal fluid and deficit schizophrenic characteristics. The British Journal of Psychiatry : the Journal of Mental Science. 156: 501-7. PMID 1696842 DOI: 10.1192/Bjp.156.4.501  0.312
1989 Faustman WO, Moses JA, Csernansky JG, White PA. Correlations between the MMPI and the Brief Psychiatric Rating Scale in schizophrenic and schizoaffective patients. Psychiatry Research. 28: 135-43. PMID 2748768 DOI: 10.1016/0165-1781(89)90041-3  0.338
1989 Faull KF, King RJ, Barchas JD, Csernansky JG. CSF phenylacetic acid and hostility in paranoid schizophrenia. Psychiatry Research. 30: 111-8. PMID 2616681 DOI: 10.1016/0165-1781(89)90152-2  0.355
1989 Prosser ES, Pruthi R, Csernansky JG. Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride. Psychopharmacology. 99: 109-16. PMID 2506596 DOI: 10.1007/Bf00634463  0.321
1988 Uhr SB, Jackson K, Berger PA, Csernansky JG. Effects of verapamil administration on negative symptoms of chronic schizophrenia. Psychiatry Research. 23: 351-2. PMID 3387506 DOI: 10.1016/0165-1781(88)90027-3  0.382
1988 Csernansky JG, Tacke U, Rusen D, Hollister LE. The effect of benzodiazepines on tardive dyskinesia symptoms. Journal of Clinical Psychopharmacology. 8: 154-5. PMID 3372715 DOI: 10.1097/00004714-198804000-00028  0.451
1988 Csernansky JG, Riney SJ, Lombrozo L, Overall JE, Hollister LE. Double-blind comparison of alprazolam, diazepam, and placebo for the treatment of negative schizophrenic symptoms. Archives of General Psychiatry. 45: 655-9. PMID 3289523 DOI: 10.1001/Archpsyc.1988.01800310063008  0.494
1988 Whiteford HA, Riney SJ, Savala RA, Csernansky JG. Dexamethasone nonsuppression in chronic schizophrenia. Acta Psychiatrica Scandinavica. 77: 58-62. PMID 3273153 DOI: 10.1111/J.1600-0447.1988.Tb05077.X  0.373
1988 Faustman WO, Moses JA, Csernansky JG. Luria-Nebraska performance and symptomatology in unmedicated schizophrenic patients. Psychiatry Research. 26: 29-34. PMID 3237904 DOI: 10.1016/0165-1781(88)90084-4  0.384
1988 Prosser ES, Csernansky JG, Hollister LE. Differences in the time course of haloperidol-induced up-regulation of rat striatal and mesolimbic dopamine receptors. Life Sciences. 43: 715-20. PMID 2901023 DOI: 10.1016/0024-3205(88)90143-9  0.5
1987 Beauclair L, Vinogradov S, Riney SJ, Csernansky JG, Hollister LE. An adjunctive role for ascorbic acid in the treatment of schizophrenia? Journal of Clinical Psychopharmacology. 7: 282-3. PMID 3624518 DOI: 10.1097/00004714-198708000-00037  0.539
1987 Whiteford HA, Riney SJ, Csernansky JG. Distinguishing depressive and negative symptoms in chronic schizophrenia. Psychopathology. 20: 234-6. PMID 3454446 DOI: 10.1159/000284506  0.325
1987 Csernansky JG, Glick S, Mellentin J. Differential effects of proglumide on mesolimbic and nigrostriatal dopamine function. Psychopharmacology. 91: 440-4. PMID 3108924 DOI: 10.1007/Bf00216008  0.323
1987 Finnegan KT, Terwilliger MM, Berger PA, Hollister LE, Csernansky JG. A comparison of the neurochemical and behavioral effects of clenbuterol and desipramine. European Journal of Pharmacology. 134: 131-6. PMID 3032650 DOI: 10.1016/0014-2999(87)90158-0  0.452
1987 Whiteford HA, Peabody CA, Warner MD, Berger PA, Csernansky JG. Maintenance therapies in schizophrenia. The Medical Journal of Australia. 147: 240-2. PMID 2890085 DOI: 10.5694/J.1326-5377.1987.Tb133419.X  0.357
1987 Prosser ES, Csernansky JG, Kaplan J, Thiemann S, Becker TJ, Hollister LE. Depression, parkinsonian symptoms, and negative symptoms in schizophrenics treated with neuroleptics. The Journal of Nervous and Mental Disease. 175: 100-5. PMID 2879880 DOI: 10.1097/00005053-198702000-00006  0.478
1986 Csernansky JG, Csernansky CA, King R, Hollister LE. Oscillations in apomorphine-induced stereotypies during 1 year of apomorphine administration. Biological Psychiatry. 21: 402-5. PMID 3955116 DOI: 10.1016/0006-3223(86)90170-8  0.442
1986 Csernansky JG, Csernansky CA, Mellentin JD, Hollister LE. Carbamazepine and dopaminergic supersensitivity. Biological Psychiatry. 21: 238-9. PMID 3947704 DOI: 10.1016/0006-3223(86)90159-9  0.447
1986 Csernansky JG, Vinogradov S, Prosser E, Kaplan J, Berger PA, Hollister LE. Associations among plasma prolactin levels, tardive dyskinesia, and paranoia in treated schizophrenics: relevance to supersensitivity psychosis. Psychopharmacology Bulletin. 22: 897-9. PMID 2879311  0.397
1986 Csernansky JG, Prosser E, Kaplan J, Mahler E, Berger PA, Hollister LE. Possible associations among plasma prolactin levels, tardive dyskinesia, and paranoia in treated male schizophrenics. Biological Psychiatry. 21: 632-42. PMID 2871874 DOI: 10.1016/0006-3223(86)90124-1  0.493
1985 Csernansky JG, Csernansky CA, Hollister LE. 3[H]-Sulpiride labels mesolimbic non-dopaminergic sites that bind antidepressant drugs. Experientia. 41: 1419-21. PMID 4065296 DOI: 10.1007/Bf01950013  0.438
1985 Csernansky JG, Csernansky CA, Bonnet KA, Hollister LE. Dopaminergic supersensitivity follows ferric chloride-induced limbic seizures. Biological Psychiatry. 20: 723-33. PMID 4039950 DOI: 10.1016/0006-3223(85)90151-9  0.497
1985 Csernansky CA, Csernansky JG, Hollister LE. A comparison between centrifugation and filtration as a means to separate bound and unbound ligand during 3[H]-spiroperidol binding. Journal of Pharmacological Methods. 13: 187-91. PMID 3999754 DOI: 10.1016/0160-5402(85)90018-X  0.426
1985 Csernansky JG, Csernansky CA, Glick SA, Hollister LE. Lidocaine kindling is accompanied by an increase in apomorphine stereotypy and mesolimbic dopamine D2 receptor density. Psychopharmacology Bulletin. 21: 707-11. PMID 2930865  0.371
1985 Csernansky JG, Kaplan J, Hollister LE. Problems in classification of schizophrenics as neuroleptic responders and nonresponders. The Journal of Nervous and Mental Disease. 173: 325-31. PMID 2860202 DOI: 10.1097/00005053-198506000-00001  0.48
1984 Csernansky JG, Csernansky CA, Hollister LE. Distinct effects of two stresses on the behavioral response to apomorphine. Life Sciences. 35: 1513-8. PMID 6541282 DOI: 10.1016/0024-3205(84)90169-3  0.458
1984 Csernansky JG, Lombrozo L, Gulevich GD, Hollister LE. Treatment of negative schizophrenic symptoms with alprazolam: a preliminary open-label study. Journal of Clinical Psychopharmacology. 4: 349-52. PMID 6150950 DOI: 10.1097/00004714-198412000-00013  0.524
1983 Csernansky JG, Holman CA, Hollister LE. Variability and the dopamine hypothesis of schizophrenia. Schizophrenia Bulletin. 9: 325-8. PMID 6622990 DOI: 10.1093/Schbul/9.3.325  0.53
1983 Csernansky JG, Holman CA, Bonnet KA, Grabowsky K, King R, Hollister LE. Dopaminergic supersensitivity at distant sites following induced epileptic foci. Life Sciences. 32: 385-90. PMID 6402628 DOI: 10.1016/0024-3205(83)90084-X  0.474
1983 Magliozzi JR, Kanter SL, Csernansky JG, Hollister LE. Detection of marijuana use in psychiatric patients by determination of urinary delta-9-tetrahydrocannabinol-11-oic acid. The Journal of Nervous and Mental Disease. 171: 246-9. PMID 6300320 DOI: 10.1097/00005053-198304000-00007  0.471
1983 Csernansky JG, Kaplan J, Holman CA, Hollister LE. Serum neuroleptic activity, prolactin, and tardive dyskinesia in schizophrenic outpatients. Psychopharmacology. 81: 115-8. PMID 6138793 DOI: 10.1007/Bf00429003  0.467
Show low-probability matches.